Safety and efficacy of immune checkpoint inhibitors in advanced cancer patients with autoimmune disease: A meta-analysis

por Cai, Qi, Huo, Geng-wei, Zhu, Fu-yi, Yue, Ping, Yuan, Dong-qi, Chen, Peng
Publicado 2022

The incidence of gastrointestinal adverse events in patients with advanced non-small cell lung cancer (NSCLC) treated with PD-1 inhibitors: a meta-analysis

por Huo, Geng-Wei, Zhu, Fu-Yi, Zuo, Ran, Song, Ying, Chen, Wei-Dong, Chen, Wen-Ming, Zhang, Hong-Mei, Jia, Sha-Sha, Chen, Peng
Publicado 2021